Skip to main content
. 2022 Jun 16;25(7):104613. doi: 10.1016/j.isci.2022.104613

Table 1.

Patient characteristics of the dx cohort (n = 50)

Patient no. Patient age [months] Treatment protocol sex Time to event (last follow-up) [months] HOXA9 ΔCT Mean IRX1
ΔCT Mean
EGR3
ΔCT Mean
ICOSLG ΔCT Mean
1 5.0 Interfant-06 F (40.1) 13.3592 6.1705 8.1850 7.6499
2 6.0 / F / 3.9204 7.7667 11.2758 8.0223
3 2.0 Interfant-06 F (23.6) 12.9546 7.1581 9.3618 7.1255
4 6.0 Interfant-06 M (17.1) 11.5783 7.9774 11.1637 7.8868
5 10.0 / M / 3.5974 8.3317 8.8214 6.0364
6 2.0 Interfant-06 M (83.6) 4.9698 9.5555 11.5618 6.8416
7 3.0 Interfant-06 F (5.6) 11.0093 5.1167 8.5196 5.6658
8 3.0 Interfant-06 F (1.2) 4.9163 6.4184 8.2271 4.8055
9 3.0 Interfant-06 M (2.5) 4.5976 9.0338 8.0114 9.8380
10 6.0 Interfant-06 F 9.5 (10.7) 5.0818 8.4812 12.3136 9.3984
11 0.1 / F / 8.6964 8.0250 11.2989 9.9469
12 1.0 / M / 12.3443 6.0576 11.6236 8.4245
13 12.0 / F / 2.2824 7.9734 9.1826 7.9894
14 4.0 / F / 11.4825 6.3166 11.4695 9.0590
15 2.0 Interfant-06 M 6.0 (6.0) 4.6973 5.9447 13.3440 8.7451
16 5.5 Interfant-06 M 9.5 (15.0) 6.2129 6.5399 9.5330 8.2498
17 1.5 Interfant-06 F 10.0 (13.0) 6.0703 4.9900 6.2132 4.0517
18 3.0 Interfant-06 F 6.0 (11.5) 2.0906 8.4791 9.4723 8.5023
19 2.0 Interfant-06 F 10.5 (19) 7.8537 3.1429 7.2056 5.2518
20 1.5 Interfant-06 M 26.5 (41.0) 4.4627 8.3685 11.2026 7.5564
21 6.5 Interfant-06 M 24.0 (32.8) 11.2673 5.3156 8.7817 8.6026
22 6.0 Interfant-06 F 19.5 (23.5) 11.5891 7.0636 10.0553 7.8697
23 12.0 Interfant-06 F 32.0 (60.6) 11.1226 4.2582 8.0600 7.3822
24 9.0 Interfant-06 M (84.9) 8.7665 2.2034 7.0569 5.8906
25 2.0 Interfant-06 F (118.8) 4.6017 7.1138 10.2925 7.1171
26 3.0 Interfant-06 M 8.0 (108.5) 13.0872 5.9083 8.7375 8.5604
27 5.5 Interfant-06 M (9.0) 5.9626 8.1536 9.1105 8.6464
28 5.0 Interfant-06 M 17.0 (33.0) 5.9922 4.8934 5.0456 3.8081
29 2.0 Interfant-06 F 56.0 (58.6) 5.3297 8.4461 9.3271 8.9127
30 1.5 Interfant-06 F (146.1) 5.8358 8.0518 9.8910 8.1978
31 8.3 Interfant-06 F (109.3) 2.2195 6.2132 6.5075 6.2880
32 8.2 Interfant-06 M (95.9) 1.7726 7.4956 7.2074 7.4143
33 10.7 Interfant-06 M 8.8 (8.8) 2.6953 3.0935 2.4138 4.9064
34 1.7 Interfant-06 F (91.5) 3.8579 7.1200 6.2540 7.6448
35 11.7 Interfant-06 F (73.2) 2.9311 7.9152 10.9273 7.2855
36 10.4 Interfant-06 F (75.9) 5.7541 8.8581 10.4144 9.1282
37 2.4 Interfant-06 F (73.8) 13.3331 6.1426 9.8438 9.0200
38 4.5 Interfant-06 M 16.1 (63.5) 4.6562 8.9152 11.4891 8.7484
39 1.1 Interfant-06 F 3.3 (15.7) 12.9071 6.3552 11.9464 9.3496
40 5.3 Interfant-06 M (58.7) 5.4284 8.4380 10.3705 8.3493
41 6.9 Interfant-06 F (63.2) 9.2472 8.5374 9.7053 6.0532
42 5.3 Interfant-06 M (60.7) 3.4737 7.4371 9.5640 7.1599
43 0.6 Interfant-06 F 5.0 (11.9) 7.9122 6.2711 8.6364 8.0174
44 1.5 Interfant-06 M 17.3 (18.3) 8.1333 8.0008 9.5745 7.1672
45 4.4 Interfant-06 M 6.6 (10.8) 4.2993 8.0016 10.2528 8.4346
46 9.1 Interfant-06 F 39.7 (45.2) 3.1663 7.7915 9.3985 8.2159
47 0.5 Interfant-06 F 8.7 (13.3) 6.2701 6.5276 9.9358 7.8396
48 6.1 AIEOP-BFM ALL 2017 F 6.6 12.6734 4.2609 9.4741 4.7534
49 6.1 AIEOP-BFM ALL 2017 F 8.3 4.5847 8.1496 10.5529 7.6922
50 10.6 / M / 5.0774 9.4705 5.1199 5.4875

All samples were taken from PB at the day of diagnosis. Gene expression values are indicated as the ΔCT mean of three technical replicates. F = female, M = male.